Trial ID or NCT#

NCT00867360

Status

not recruiting iconNOT RECRUITING

Purpose

The purpose of this research study is to see how certain hormones cause changes in mood and thinking in some depressed patients and to determine the effectiveness of mifepristone in treating some forms of depression. This study is conducted in conjunction with an observational study "Clinical and Biological Characteristics of Psychotic Depression".

Official Title

Hypothalamic-Pituitary-Adrenal (HPA)/Dopamine Axis in Psychotic Depression

Eligibility Criteria

Ages Eligible for Study: 21 Years to 85 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Fredric Kraemer
Fredric Kraemer
Endocrinologist
Gerald M. Reaven, MD, Professor of Endocrinology

Contact us to find out if this trial is right for you.

CONTACT

Lakshika Tennakoon
(650) 723-3305